What are the contents of clinical drug research?
The contents of clinical drug research mainly include the following aspects: ** 1. Effect of the medicine ** 1. ** clinical effects ** - To determine whether the drug has a treatment effect on a specific disease, such as whether it can improve symptoms, reduce the severity of the disease, or cure the disease. This helped doctors find the best methods and drugs to improve, control, and treat diseases. 2. ** Pharmacological effects ** - To explore the pharmacology of drugs in the body, such as how the drugs interact with the body's receptor, the receptor, or other biological molecules to exert their effects. 3. ** Other functions ** - It might involve the effects of drugs on the overall physiological functions of the body, such as the immune system and metabolism. ** 2. Side effects of the drug ** - The possible adverse reactions of the study drug included mild discomfort symptoms to serious toxic reactions. This was because while the drug brought benefits to the patient, there might be some adverse reactions that had never been encountered before. The discovery of these adverse reactions was crucial for a comprehensive assessment of the safety of the drug. ** 3. Absorption, distribution, metabolism and secretion of drugs ** 1. ** Absorb ** - Understand the way drugs enter the body (such as oral administration, injection, etc.) and the speed and degree of absorption. For example, some drugs are easily dehydrated in water, and will be destroyed when they meet acid, alkalium, and oxidants, which will affect their absorption. Penicilin is generally not taken by the mouth because it is easily degraded by the presence of an enzyme. 2. ** Dispersion ** - Studying the distribution of drugs in different tissues and organs in the body would help to understand whether the drugs could reach the site of the disease. 3. ** Metabolization ** - To investigate the metabolism process of drugs in the body, including which hormones are involved in the metabolism, what the metabolism products are, and whether the metabolism products are active or toxic. 4. ** Excretion ** - To determine the way the drug and its metabolism products are discharged from the body (such as through kidney secretion, bile secretion, etc.) and the rate of secretion. ** IV. Drug effectiveness and safety ** 1. ** Validity ** - Through systematic research to confirm or discover whether the drug can achieve the expected treatment effect, such as whether it can effectively kill the pathogen and improve physiological function. 2. ** Security ** - The safety of drugs was evaluated based on the three principles of science, law, and ethics. They had to consider the risks and benefits of the drug in clinical trials to ensure that the drug would not bring unacceptable risks to the subjects while treating the disease. When intolerable adverse reactions occurred, the research team had to take emergency measures to ensure the safety of the subjects. Read more exciting novels for free
What are the humorous elements in clinical research cartoons?
Well, there could be funny characters, like a clumsy researcher or a goofy experiment. Maybe some witty dialogues or unexpected outcomes in the research process.
What are the reasons for donating blood for drug clinical trials?
First of all, clinical trials of drugs were systematic studies of drugs on humans (patients or healthy volunteers). The purpose was to determine the safety and effectiveness of the experimental drugs. Blood donation might involve the following problems: From the perspective of health effects, under normal circumstances, there would be certain physiological reactions after human blood donation. For example, people with weak constitutions and lack of exercise might feel dizzy and nauseous after donating blood, and participating in drug clinical trials might also require blood to be drawn for various tests. If one participated in the trial soon after donating blood, frequent blood drawing might be detrimental to health, because the test generally required blood to analyze the impact of the drug on the human body, which might cause the body to be overburdened. From the perspective of the accuracy of the test, blood donation may change the blood composition and physiological state of the human body, thus affecting the accuracy of the results of the clinical trial of the drug. For example, if a person participated in a drug test right after donating blood, the oxygen carrying capacity and nutrient content of the blood might be in an abnormal state, which might interfere with the test results of the absorption, distribution, metabolism, and secretion of the drug in the body, thus affecting the judgment of the safety and effectiveness of the drug. From the perspective of volunteer screening, since both blood donation and drug clinical trials involved operations related to human blood, the coordination between the two should be considered during volunteer screening. For example, some drug clinical trials required volunteers to not donate blood in the past three months. Otherwise, they might not meet the trial requirements. This increased the complexity of volunteer recruitment and screening, which might lead to a reduction in the number of suitable volunteers, affecting the progress of the trial and the representation of samples. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the types of first-level clinical drug literature?
Literature that mainly consisted of original works published in journals was classified as first-class literature. For example, the content of the literature published in the China Pharmaceutical Magazine was more comprehensive and belonged to the Chinese core pharmaceutical journals. It contained various types of original literature, which was classified as first-class literature. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is Alzheimer's disease a subject of fictional clinical research and trials?
No, Alzheimer's disease is a very real and serious condition, and clinical research and trials related to it are based on genuine scientific efforts.
What is the content of the drug research process?
The drug research process mainly included the following contents: ** 1. Candidate Drug Development (New Drug Discovered)** 1. ** Disease confirmation, target confirmation ** - First of all, it was necessary to determine the type of disease that the drug was used to treat and understand the pathogenic mechanism of the disease. This was just like determining the combat target. For example, when developing drugs for the 2019 coronaviruses, it was necessary to understand the mechanism of the virus invading cells, replicating, and releasing in the body, and to find effective targets from the signal molecules and the binding sites of the virus. 2. ** Lead compound found ** - After determining the target, they had to find the compound that had an effect on the target. Its source could be natural products, such as natural active substances excavated from animals, plants, and marine organisms, or it could be an improvement of known drugs. This process usually used high-throughout screening, computer simulation screening, rational design, and other methods to determine which compounds had medicinal development value through cell experiments. 3. ** Lead compound optimization ** - After finding the lead compound, it was necessary to analyze the relationship between its chemical structure and its efficacy, and then optimize its structure to obtain the optimal compound that could play a more effective role, which was also the candidate drug. ** II. Preclinic research ** 1. ** chemical synthesis ** - The R & D department first designed the route to synthesize the optimal compound, and then the process department designed the drug synthesis route according to the needs, and constantly adjusted the process to obtain enough compounds to meet the needs of follow-up research and clinical trials. This was also the process of perfecting the drug preparation process. 2. ** PK ** - The absorption, distribution, metabolism, and secretion of drugs in the body were studied through animal models. These research data could guide the initial formulation of the drug administration plan, such as determining the best way to administer the drug (oral, intravenous, nasal, etc.), the frequency of administration, and the dosage adjustment for special patients (such as patients with kidney failure). 3. ** Drug Safety ** - In addition to treating the target disease, evaluate the possible effects of the drug on other parts of the body, especially on important parts such as the cardiovascular system, nervous system, and organs. 4. ** Drug toxicity research ** - Study the toxicity, cancerism, reproductive toxicity, etc. of drugs taken for a long time, and avoid including drugs with serious toxic reactions in further research plans. 5. ** Formula research, formulation development ** - Based on the conclusions of the previous studies, they would develop a new drug that could finally be used on the market. ** III. clinical trial (phase I-III)** 1. ** Phase I clinical trial ** - It mainly conducted small-scale experiments on healthy volunteers, focusing on the safety of the drug, including the absorption, distribution, metabolism, and secretion of the drug in the human body to determine the safe dosage range. 2. ** Phase II clinical trial ** - Trials were conducted on patients to evaluate the treatment effect of the drug on the target disease. At the same time, the safety of the drug was further observed to explore the appropriate dosage plan. 3. ** Phase III clinical trial ** - Trials were conducted on a larger patient population to comprehensively evaluate the effectiveness and safety of the drug, providing sufficient evidence for the approval of the drug. ** IV. New drug application, marketing approval, and post-marketing monitoring (Phase IV clinical trial)** 1. ** New drug application and approval ** - The developer submitted a new drug application to the relevant department, and the drug could be sold after review and approval. 2. ** Post-marketing monitoring (Phase IV clinical trial)** - After the drug was launched, the safety and effectiveness of the drug in a large population were continuously monitored, and information on adverse reactions was collected so that the medication guidelines could be adjusted or the drug could be improved in a timely manner. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the contents of the medical drug scrap system?
The medical drug scrap system included the following aspects: 1. ** Judgment basis for scrap **: All drugs that are damaged, discolored, moldy, moth-eaten, expired, and other unqualified drugs, as well as drugs that have been confirmed by the Drug and Medical Device Management Committee to have quality problems and other reasons for not being able to sell or return, and drugs that have been confirmed to be unqualified by the pharmaceutical supervision and management department will be scrapped. 2. ** Treatment of special circumstances **: For drugs with damaged original packaging, the supplier shall be responsible for replacement and replenishment; for drugs with damaged original packaging in each pharmacy, the pharmacy shall ask for replenishment from the drug warehouse based on the damaged packaging, and the drug warehouse shall collect the damaged packaging and uniformly ask for replenishment from the supplier; for drugs with a shortage of original packaging, whether it occurs in the pharmacy or the drug warehouse, it requires more than two people to prove it. After signing by the director of the Pharmacy Department, the supplier shall be asked for replenishment. 3. ** Scrap process **: - The drug storehouse and each pharmacy shall summarize and fill in the scrap form. The scrap form must indicate the name, specifications, unit price, amount, total amount of reported loss, reason for reported loss, etc., which shall be checked and signed by the quality management team, reported to the director of the pharmacy department for review and signature, and reported to the director in charge for approval. - The drugs to be approved and scrapped should be stored separately and marked clearly. - The drugs that had been approved for scrap would be stored in the scrap warehouse and destroyed by the drug supervision department at the end of the year. - For small batches of scrapped drugs (the amount of which did not exceed 5000 yuan), the storekeeper would fill in the "Scrap Drug Destruction Form" before destroying them. The storehouse accountant would count the variety and quantity, and the drugs and medical devices administration committee would approve and sign them before destroying them according to the regulations. During the destruction, the business president, the medical department chief, the pharmacy department director, and the person in charge of safekeeping would jointly supervise. After the destruction, these people would jointly sign on the destruction form, and the destruction form would be used to write off the account and be filed. - For large batches of scrapped drugs (the amount exceeds (includes) 5000 yuan or more), after the approval of the business director, fill in the "Waste Drug Destruction Form" and report to the Food and Drug Administration before destruction. If the superior unit has no objections, it will be handled according to the procedures for small batches of scrapped drugs. - All drugs that are notified by the drug supervision and administration department or fail to pass the spot check (cannot continue to be used) shall be handled according to the requirements of the higher authorities or sealed on the spot. They shall be requested to be disposed of or destroyed by the drug supervision and administration department. They shall not be destroyed or disposed of by themselves. 4. ** Management and Supervision Requirements **: - Scrapped drugs should be strictly managed and destroyed in a timely manner to prevent them from flowing into society and harming the health of the people. - For drugs that had expired or could not be used for other reasons, the storekeeper and the drug accountant would fill in the drug destruction form. After the department director agreed, they could only destroy it after reporting it to the relevant departments of the hospital and the president. - The destroyed drugs must be registered. The contents of the record should include the name of the drug, specifications, batch number, quantity destroyed, reason for destruction, person in charge, time, place and method of destruction. At least two people must be present during the destruction. The record must be made in the drug destruction register in time and signed by two people. - The destruction of special drugs such as poisons, anesthetics, and psychotropics must be reported to the Drug Administration and supervised by the Drug Administration. - The accounts, documents, and destruction forms of general scrapped drugs shall be kept for five years; the accounts, documents, and destruction forms of scrapped anesthetics and Class I psychoactive drugs shall be kept permanently. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the research contents of Chinese medicine pharmacology?
The research content of Chinese medicine pharmacology mainly included the following aspects: 1. ** Immune regulation **: Chinese medicine can regulate the human immune system, strengthen the body's resistance, and improve the defense ability of the immune system. 2. ** Metabolic regulation **: It helps to regulate the body's metabolism and promote metabolism to maintain the body's normal physiological functions. 3. ** Anti-inflammatory, anti-bacteria, and anti-virus effects **: It can suppress inflammation, suppress the growth and reproduction of bacteria and viruses, and reduce the symptoms of infection. 4. ** Regulates nervous system function **: It can regulate the excitatory and suppressive properties of the nervous system and improve nervous system imbalance. 5. ** Adjusts the function of the cardiovascular system **: It can regulate the function of the cardiovascular system, such as lowering blood pressure, lowering blood fat, and resisting blood clots, thereby reducing the risk of cardiovascular and cardiovascular diseases. It should be noted that the pharmacology of Chinese medicine is closely related to factors such as dosage, composition, compatibility, etc. It should be used reasonably under the guidance of a doctor to avoid adverse reactions. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Table of contents of the medical skill volume of the three basic training in clinical medicine
The contents of the medical skill volumes of the three basic training in clinical medicine may vary according to different versions and editors. The following is a possible table of contents: 1. Basic knowledge: - anatomy - Physiology - pathology - pharmacology - medical ethics 2. Clinic Skills: - diagnostics - epidemiology - iatreusiology - health Statistics - medical imaging 3. Medical Skill Manipulation: - Stomatology - ophthalmology department - gynaecology and obstetrics - pediatric department - surgical - Department of Anesthesiology 4. Laws and Regulations: - Health Law of the People's Republic of China - Medical Device Safety Law of the People's Republic of China - clinical practice standards of medical institutions The above table of contents is for reference only. The specific contents of the table of contents may vary according to different versions and editors.
Salivary cancer effective drug research and development
The research and development of drugs for Salivary Gland Cancer had made progress in many aspects. In terms of drug therapy research based on the ESCat classification, the drug therapy for Salivary Gland Cancer was divided into four types: one was the NTrK fusion inhibition drugs Entritini and Larotinib, and the other was targeted at the over-expression of HEL2.(For example, trastuzumab-pertuzumab-pertuzumpertuzum-pertuzum-pertuzumpertuzum In terms of anti-HEL2 therapy, studies have shown that trastulizumab-plus-taxotere in the treatment of HEL-amplified saliva gland cancer has achieved an objective response rate (ORR) of 70.2%, and in the treatment of patients with HEL2 overexpressed or amplified saliva gland cancer with patotubizumab-plus-tratotubizumab-plus-taxotere, the ORR has reached 60%. In 2021, a study conducted by AscO used the ADC drug, DS - 8201, to treat patients with SADC as second-line therapy. The PR rate reached 47.1% and the DOR was 12.9 months. It was confirmed that HER-2 was a driver gene of saliva gland cancer. In a study reported at the 2024 Annual Meeting of the American Society of Clinic Oncers (Asco), pirotinib (an oral irreversible pan-Her receptor Tyrosin Kinase) was used to treat HER2 variant advanced stage Salivary Gland Cancer (SGC). The efficacy and safety of pirotinib in patients with HER2 amplification, over-expression, or mutation in advanced SGC were being evaluated. In terms of anti-androgen therapy, anti-androgen therapy for Salivary Ductal Carcinomas (SDCs) was the highest AR expression subclass in saliva glands. The study showed that leuprorelin + bicalutamide treatment for patients with Salivary Ductal Carcinomas (34 SDCs and 2 other patients) achieved a PR + PR rate of 41.7%. After 24 patients (19 SDCs) failed previous ADT, they were treated with abraterone + Prednisone + LHGH Analogy as a salvage plan. The ORR was 21% and the DPR was 62.5%. In addition, in the case of a malignant tumor of the saliva gland, the study found that the small molecular inhibition of MMD2 could reduce the number of cancer stem cells and reduce the relapse rate of mice. Although there was no FDa-approved drug for the treatment of this cancer, it provided a new direction for the treatment of saliva gland cancer. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the topics of the proposal report on drug research?
The following are some examples of topics related to drug research proposals: - Study on the preparation and determination of the physical and chemical properties of the micro-capsule suspension concentrate. - A study on the effectiveness of a comprehensive treatment plan based on electronic drug monitors for Xizang patients with malaria (This is a derivative topic of the relevant research of Shandong University of Traditional Chinese Medicine). Of course, there were many other topics in the drug research proposal, such as the treatment effect of a specific drug on a certain disease, the development of new drug forms, and the evaluation of drug safety. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>